Over the past few months, the UK’s regulator of medicines (Medicines & Healthcare products Regulatory Agency) has issued a series of alerts relating to Emerade adrenaline pens. These are devices used in the emergency treatment of severe allergic reactions or ‘anaphylaxis’. Tests indicated that approximately 13% of pens needed a higher than normal force to activate which could lead to doses not being delivered.
Initial advice to patients was to always carry two pens, to press the device firmly if used and to try again if it failed to activate. Now there are sufficient stocks of alternative brands so patients are able to replace their Emerade pens with an alternative. The alternative brands come in a maximum strength of 300mcg but don’t worry if you had an Emerade 500mcg pen – the evidence suggests that an Epipen or Jext 300mcg pen will be a suitable replacement for you and these actually deliver a similar amount of drug.
We have identified affected patients on our clinical system and have issued new prescriptions for Epipen or Jext. Patients should return their Emerade brand pens to the pharmacy when they go to collect.
If you have Emerade pens at home and have not received a text message from us, please contact the practice to arrange a replacement.
For further information, see www.anaphylaxis.org.uk/tag/emerade